Clinovo
Sunnyvale, US · Founded 2013 · 1 known investors
Clinovo provides clinical trial workforce solutions for biotech sponsors and CROs, offering staff augmentation, functional service provider (FSP) models, and AI-powered digital teammates (ClinAI). Its services support clinical operations across trial stages, from early-stage rare disease studies to late-stage oncology and multi-site programs.
Founders & leadership
AG
Ale GicqueauNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$150K disclosed across 1 round · 2013
▶$150KraisedMar 2014 · 6 investors · Other TechnologyRule 506(c)
▶$150KraisedMar 2014 · 6 investors · Other Technology
Rule 506(c)Officers, directors & promoters on the filing
- Ale GicqueauExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $150K
- Minimum investment
- $10K
- Finders' fees
- $120K
- Placement agents
- I-Banker Securities, Inc.
- First sale
- Dec 2013
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Clinovo do?
- Clinovo provides clinical trial workforce solutions for biotech sponsors and CROs, offering staff augmentation, functional service provider (FSP) models, and AI-powered digital teammates (ClinAI). Its services support clinical operations across trial stages, from early-stage rare disease studies to late-stage oncology and multi-site programs.
- Who are Clinovo's investors?
- Clinovo's investors include Keiretsu Forum.
- How much funding has Clinovo raised?
- Clinovo has disclosed $150K raised across 1 round.
- Where is Clinovo headquartered?
- Clinovo is headquartered in Sunnyvale, US.